Dauer, Patricia
Gupta, Vineet K.
McGinn, Olivia
Nomura, Alice
Sharma, Nikita S.
Arora, Nivedita
Giri, Bhuwan
Dudeja, Vikas
Saluja, Ashok K.
Banerjee, Sulagna
Article History
Received: 7 December 2016
Accepted: 31 March 2017
First Online: 8 May 2017
Competing Interests
: University of Minnesota has a patent for Minnelide, which has been licensed to Minneamrita Therapeutics, LLC. AKS is the co-founder and the Chief Scientific Officer of this company. SB is a consultant with Minneamrita Therapeutics LLC and this relationship is managed by University of Miami. The remaining authors declare no conflict of interest.